November 1, 2012

Nestlé on Tuesday named Luis Cantarell head of Nestlé Nutrition with the departure of Kurt Schmidt, deputy EVP Nestlé Nutrition, who has decided to leave the company for personal reasons effective Dec. 1.

October 31, 2012

Walgreens on Tuesday announced that it has formally set up a new company, jointly owned with Alliance Boots, as part of their strategic partnership’s synergy program.

October 26, 2012

A Swiss subsidiary of drug maker Celgene Corp. said its chemotherapy drug produced "significant" improvement in progression-free survival in patients with a deadly skin cancer that had spread elsewhere in the body.

October 26, 2012

Progress at re-opening its manufacturing facility in Lincoln, Neb., has been slow-going, Novartis reported Thursday, but the company has contracted third-party manufacturers to resume production of Excedrin, Lamisil and Triaminic.

June 1, 2012

While headlines in the past two weeks warned consumers that calcium supplementation could increase the risk of cardiovascular disease, authors of the study that prompted those headlines — published last month in the peer-reviewed journal Heart — identified four significant confounding factors in the design of the study.

May 10, 2012

Generic drug maker Watson Pharmaceuticals has formed a special office to handle its pending acquisition of Actavis, the company said.

May 2, 2012

Novartis' generics division has acquired Fougera Pharmaceuticals, the company said Wednesday.

April 19, 2012

The Council for Responsible Nutrition-International on Thursday named several new officers to its board of directors.

April 18, 2012

Roche has decided not to buy diagnostics firm Illumina, the drug maker said Wednesday.

April 17, 2012

A U.S. drug maker has made a deal with a Swiss company to manufacture and sell a new osteoporosis treatment in North America.

March 15, 2012

The Food and Drug Administration approved an effervescent tablet for treating osteoporosis.

December 22, 2011

A Swiss drug maker is acquiring the U.S. rights for several GlaxoSmithKline drugs.

November 10, 2011

The Food and Drug Administration has accepted a new drug application for a skin cancer treatment developed by Roche.

November 3, 2011

Procter & Gamble on Thursday announced the creation of a new partnership and joint venture with Teva Pharmaceutical Industries to be named PGT Healthcare.

September 29, 2011

Roche has received approval from the Food and Drug Administration for its new generation of blood-glucose test strips.

September 28, 2011

Nestlé EVP and CFO Jim Singh will retire in March 2012 after 35 years with the company.

August 8, 2011

An investigational treatment made by Roche for asthma increased lung function in patients who could not adequately control their disease with inhaled corticosteroids, according to results of a mid-stage clinical trial.

May 24, 2011

Alterna, a marketer of personal care products and therapeutic over-the-counter medicines, has signed a new trademark and know-how license agreement with Spirig Pharma AG of Egerkingen, Switzerland, which expands Alterna's exclusive rights to distribute Kerasal one-step exfoliating moisturizing foot ointment to 80 countries outside of North America.

March 24, 2011

The Food and Drug Administration has extended its regulatory review period for Novartis' new drug application for its once-daily, long-term maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease, as well as chronic bronchitis and/or emphysema, the drug maker said.

March 8, 2011

Nestle is looking to boost its coffee business.

February 17, 2011

Novartis on Thursday morning named Naomi Kelman head of the Novartis OTC division, effective March 2. She will report directly to Joseph Jimenez, Novartis CEO.

February 2, 2011

Nestlé Health Sciences completed its acquisition of a company that develops "medical foods" for such medical conditions as kidney disease, inflammatory bowel disease and colon cancer.

February 1, 2011

The Food and Drug Administration has approved a Novartis vaccine for preventing meningococcal disease in children, the Swiss drug maker said.

January 27, 2011

Swiss drug maker Novartis posted sales of $14.2 billion for fourth quarter 2010 and $50.6 billion for the year as a whole, according to an earnings report released Thursday.